These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 590329)

  • 1. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.
    Stoof JC; Mulder AH
    Eur J Pharmacol; 1977 Nov; 46(2):177-80. PubMed ID: 590329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro.
    Starr MS
    Eur J Pharmacol; 1979 Jan; 53(3):215-26. PubMed ID: 759200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones.
    Giorguieff-Chesselet MF; Besson MJ; Cheramy A; Glowinski J
    J Physiol (Paris); 1979; 75(6):611-3. PubMed ID: 547062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aminooxyacetic acid on the potassium-evoked release of [3H]gamma-aminobutyric acid from slices of rat cerebral cortex.
    Bedwani JR; Songra AK; Trueman CJ
    Neurochem Res; 1984 Aug; 9(8):1101-8. PubMed ID: 6493442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat.
    Gundlach AL; Beart PM
    J Pharm Pharmacol; 1981 Jan; 33(1):41-3. PubMed ID: 6114152
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
    Wood PL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
    Silbergeld EK; Walters JR
    Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of radiolabelled metabolites in release studies using [3H]gamma-aminobutyric acid.
    Gardner CR; Richards MH
    J Neurochem; 1981 Apr; 36(4):1590-3. PubMed ID: 7264654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The purported dopamine agonist DPI inhibits [3H]noradrenaline release from rat cortical slices but not [3H]dopamine and [14C]acetylcholine release from rat striatal slices in-vitro.
    Van Oene JC; Sminia P; Mulder AH; Horn AS
    J Pharm Pharmacol; 1983 Dec; 35(12):786-92. PubMed ID: 6141240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors.
    Hotchkiss A; Gibb JW
    Eur J Pharmacol; 1980 Aug; 66(2-3):201-5. PubMed ID: 6108224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA modulates the release of dopamine and acetylcholine from rat caudate nucleus slices.
    Stoof JC; Den Breejen EJ; Mulder AH
    Eur J Pharmacol; 1979 Jul; 57(1):35-42. PubMed ID: 477740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple opiate receptors may be involved in suppressing gamma-aminobutyrate release in substantia nigra.
    Starr MS
    Life Sci; 1985 Dec; 37(24):2249-55. PubMed ID: 2999545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of isolation-induced aggressive behavior with GABA transaminase inhibitors.
    DaVanzo JP; Sydow M
    Psychopharmacology (Berl); 1979 Mar; 62(1):23-7. PubMed ID: 108744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA in the intralaminar thalamic nuclei modulates dopamine release from the two dopaminergic nigro-striatal pathways in the cat.
    Romo R; Chéramy A; Desban M; Godeheu G; Glowinski J
    Brain Res Bull; 1983 Dec; 11(6):671-80. PubMed ID: 6318917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
    Starr MS
    Neurosci Lett; 1980 May; 18(1):79-84. PubMed ID: 6133247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen.
    Midgley LP; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Oct; 593(1):89-96. PubMed ID: 1360868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra.
    Marchi M; Augliera A; Codignola A; Lunardi G; Fedele E; Fontana G; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):275-80. PubMed ID: 1961254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.